Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04139304 |
Title | A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | AIDS Malignancy Consortium |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Miami Miller School of Medicine | Miami | Florida | 33136 | United States | Details | |
University of Illinois at Chicago | Chicago | Illinois | 60612 | United States | Details | |
Johns Hopkins University/Sidney Kimmel Cancer Center | Baltimore | Maryland | 21231 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10021 | United States | Details | |
University of North Carolina - Chapel Hill | Chapel Hill | North Carolina | 27514 | United States | Details | |
The Ohio State University | Columbus | Ohio | 43210 | United States | Details | |
University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States | Details | |
The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |